|
|
| Nomenclature |
|
Symbol:
|
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
|
|
Name:
|
transgene insertion 1, Dennis M Zaller
|
|
MGI ID: |
MGI:3809457 |
|
Synonyms: |
DR1, DR1 Tg, HLA-DR1, Tg(HLA-DRB1*01)1Dmz |
|
Transgene:
|
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
Location:
unknown
Genetic Position: Chr5,
Syntenic
|
|
Transgene
origin |
|
Strain of Origin:
|
(C57BL/6 x SJL/J)F2
|
|
Transgene
description |
|
Transgene
Type: | |
Transgenic (random, expressed) |
|
Mutation: | |
Insertion |
| |
|
Mutation details: A chimeric MHC class II complex was created by fusing the human peptide binding domains of class II alpha and beta chains to the CD4 binding domains of murine class II alpha or beta chains. The was done by the construction of two separate transgene constructs. The alpha1 and beta1 domains isolated from human DRA1*0101 and DRB1*0101 replaced the corresponding alpha1 and beta1 domains of the H2-Ea and H2-Eb1 genes that make up mouse I-Ed. The native murine promoters were left intact. These transgene constructs were co-injected into fertilized oocytes and the founder mice with the highest expression of the chimeric MHC was chosen for further propagation. Flow cytometry analysis indicates that virtually all cells in peripheral blood that express endogenous MHC-II also express the chimeric MHC-II. The transgene construct was later shown (in J:126700) to have inserted into chromosome 5. (J:108635, J:126700)
|
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
|
Disease models
|
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
| References |
|
Original: |
J:108635
Rosloniec EF et al.,
"An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen."
J Exp Med 1997 Mar 17;185(6):1113-22
|
|
All: |
5 reference(s)
|
|
Analysis Tools
